Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2025.

Explore why Qualcomm (QCOM) remains a strong 'Buy' with resilient growth, record Q1 2025 earnings, and >22% upside potential ...

With rising demand for advanced nodes, AI chips and high-bandwidth memory, ASML's lithography tools will remain mission-critical, making the stock worth buying.

S&P 500, Alphabet Inc Class A, Tesla Inc, Samsung Electronics Co Ltd. Read 's Market Analysis on Investing.com ...

Inside a state-of-the-art factory floor in Noida, operated by Optiemus Electronics Ltd (OEL) – a facility boasting advanced ...

Apple appears set to continue its push into the mid-range smartphone market, with fresh rumors suggesting the iPhone 17e is ...

A year that feels like we’re living in a sci-fi novel, except Elon Musk is still a protagonist, and somehow Khloe Kardashian ...

Verizon has announced its revenue in Q1 2025 grew 1.5 percent from a year ago to $33.5 billion., despite loss of subscribers.

Watch your favourite team lift the IPL trophy on the big screen! Bring home a new smart TV at up to 75% discount on Amazon ...

Before President Trump's tariff announcement triggered a market crash, Meta's Mark Zuckerberg, JP Morgan Chase's Jamie Dimon, ...

The ClearBridge International Value Strategy outperformed its MSCI EAFE benchmark during the first quarter of 2025. Click ...

STOCKHOLM] Sweden’s Ericsson is planning to manufacture all its telecom antennas for the Indian market in the South Asian ...